Reports - Clinical Oncology Next Generation Sequencing Market
HealthcareClinical Oncology Next Generation Sequencing Market
Clinical Oncology Next Generation Sequencing Market Size and Share Analysis for 2035 by Types (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing Centrifuges) by Applications (Hospitals, Clinics, Laboratories) by Region (North America, Europe, Asia Pacifica, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Clinical Oncology Next Generation Sequencing Market - Segment Analysis
1. Overview
2. Global Clinical Oncology Next Generation Sequencing Market, 2020 - 2032 (USD Million)
3. Global Clinical Oncology Next Generation Sequencing Market - by Types
3.1. By Whole Genome Sequencing
3.2. By Whole Exome Sequencing
3.3. By Targeted Sequencing & Resequencing Centrifuges
4. Global Clinical Oncology Next Generation Sequencing Market - by Applications
4.1. By Hospitals
4.2. By Clinics
4.3. By Laboratories
5. Global Clinical Oncology Next Generation Sequencing Market - by region
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Latin America
5.5. Middle East & Africa
6. Market comparative analysis
Chapter 4 North America Clinical Oncology Next Generation Sequencing Market - Segment Analysis
1. Overview
2. North America Clinical Oncology Next Generation Sequencing Market, 2020 - 2032 (USD Million)
3. North America Clinical Oncology Next Generation Sequencing Market - by Types
3.1. By Whole Genome Sequencing
3.2. By Whole Exome Sequencing
3.3. By Targeted Sequencing & Resequencing Centrifuges
4. North America Clinical Oncology Next Generation Sequencing Market - by Applications
4.1. By Hospitals
4.2. By Clinics
4.3. By Laboratories
Chapter 5 Europe Clinical Oncology Next Generation Sequencing Market - Segment Analysis
1. Overview
2. Europe Clinical Oncology Next Generation Sequencing Market, 2020 - 2032 (USD Million)
3. Europe Clinical Oncology Next Generation Sequencing Market - by Types
3.1. By Whole Genome Sequencing
3.2. By Whole Exome Sequencing
3.3. By Targeted Sequencing & Resequencing Centrifuges
4. Europe Clinical Oncology Next Generation Sequencing Market - by Applications
4.1. By Hospitals
4.2. By Clinics
4.3. By Laboratories
Chapter 6 Asia Pacific Clinical Oncology Next Generation Sequencing Market - Segment Analysis
1. Overview
2. Asia Pacific Clinical Oncology Next Generation Sequencing Market, 2020 - 2032 (USD Million)
3. Asia Pacific Clinical Oncology Next Generation Sequencing Market - by Types
3.1. By Whole Genome Sequencing
3.2. By Whole Exome Sequencing
3.3. By Targeted Sequencing & Resequencing Centrifuges
4. Asia Pacific Clinical Oncology Next Generation Sequencing Market - by Applications
4.1. By Hospitals
4.2. By Clinics
4.3. By Laboratories
Chapter 7 Latin America Clinical Oncology Next Generation Sequencing Market - Segment Analysis
1. Overview
2. Latin America Clinical Oncology Next Generation Sequencing Market, 2020 - 2032 (USD Million)
3. Latin America Clinical Oncology Next Generation Sequencing Market - by Types
3.1. By Whole Genome Sequencing
3.2. By Whole Exome Sequencing
3.3. By Targeted Sequencing & Resequencing Centrifuges
4. Latin America Clinical Oncology Next Generation Sequencing Market - by Applications
4.1. By Hospitals
4.2. By Clinics
4.3. By Laboratories
Chapter 8 Middle East & Africa Clinical Oncology Next Generation Sequencing Market - Segment Analysis
1. Overview
2. Middle East & Africa Clinical Oncology Next Generation Sequencing Market, 2020 - 2032 (USD Million)
3. Middle East & Africa Clinical Oncology Next Generation Sequencing Market - by Types
3.1. By Whole Genome Sequencing
3.2. By Whole Exome Sequencing
3.3. By Targeted Sequencing & Resequencing Centrifuges
4. Middle East & Africa Clinical Oncology Next Generation Sequencing Market - by Applications
4.1. By Hospitals
4.2. By Clinics
4.3. By Laboratories
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Illumina Inc.
2. Thermo Fisher Scientific
3. F. Hoffmann-La Roche Ltd.
4. Agilent Technologies
5. Myriad Genetics
6. Beijing Genomics Institute (BGI)
7. Perkin Elmer
8. Foundation Medicine
9. Pacific Bioscience
10. Oxford Nanopore Technologies Ltd.
11. Paradigm Diagnostics
12. Caris Life Sciences
13. Partek Inc.
14. Eurofins Scientific S.E.
15. Qiagen N.V.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By